Clinical trials
Recruiting Leukemia, Myeloid, Chronic-Phase trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Enliven Therapeutics | 2 |
| M.D. Anderson Cancer Center | 2 |
| Medical College of Wisconsin | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Centre Hospitalier Henri Duffaut - Avignon | 1 |
| City of Hope Medical Center | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| Il-Yang Pharm. Co., Ltd. | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Chronic-Phase | 19 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 9 |
| Leukemia, Myeloid, Accelerated Phase | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Hodgkin Disease | 3 |
| Leukemia | 3 |
| Leukemia, Biphenotypic, Acute | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.